Gregory Glover Questions & Answers

July 8, 2018

Dr. Gregory Glover at the 2018 Annual Mensa Conference - Questions & Answers

Practice Expertise

Regulatory IP:

Essentials of Lifecycle Management

The lifecycle management tools covered in this guide will help enhance value for biopharmaceutical investors, developers, and manufacturers and strengthen the incentives for continued medical progress.

Learn More

Gregory Glover | Blog

January 4, 2024

Competitive Effects of Overlapping Drug Exclusivities

Growth in orphan drug sales is surpassing growth in the broader pharmaceuticals market. Analysts estimate that top-selling orphan drugs like Darzalex and Ultomiris will make up 20% of all prescription drug sales by 2026. With sales hitting $160.5 billion in 2021, estimates... More

Washington D.C.
Pharmaceutical IP Lawyer of the Year